In vivo generated chimeric antigen receptor T cells reduce fibrosis and restore cardiac function in experimental heart failure

In vivo generated chimeric antigen receptor T cells reduce fibrosis and restore cardiac function in experimental heart failure

Bibliographic Details
Main Authors:	Liuzzo, G. (Author), Patrono, C. (Author)
Format:	Article
Language:	English
Published:	NLM (Medline) 2022
Subjects:	fibrosis Fibrosis heart failure Heart Failure human Humans Receptors, Chimeric Antigen T lymphocyte T-Lymphocytes
Online Access:	View Fulltext in Publisher

Similar Items

Markers of fibrosis in ischemic chronic heart failure and renal dysfunction
by: V. D. Syvolap, et al.
Published: (2015-06-01)

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
by: Mark Sweeney, et al.
Published: (2020-10-01)

Markers of fibrosis, renal function in ischemic chronic heart failure in late stage of the postinfarction remodeling
by: D. A. Lashkul
Published: (2015-08-01)

Role of microRNAs in cardiac hypertrophy, myocardial fibrosis and heart failure
by: De-li Dong, et al.
Published: (2011-06-01)

Endothelial Transformation Related Protein 53 Deletion Promotes Angiogenesis and Prevents Cardiac Fibrosis and Heart Failure Induced by Pressure Overload in Mice
by: Gogiraju, Rajinikanth
Published: (2015)

Prognostic significance of liver stiffness assessed by fibrosis‐4 index in patients with heart failure
by: Masafumi Takae, et al.
Published: (2021-10-01)

Extracellular matrix remodeling in patients with ischemic chronic heart failure with preserved ejection fraction
by: V. D. Syvolap, et al.
Published: (2015-04-01)

Biomarkers of myocardial fibrosis and their genetic regulation in patients with heart failure
by: T. B. Pecherina, et al.
Published: (2020-11-01)

Predictive value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in decompensated heart failure
by: Mahmoud Ashry, et al.
Published: (2019-01-01)

Role of the cardiac extracellular matrix in the onset and progression of heart failure
by: N. N. Ilov, et al.
Published: (2021-07-01)

The effects of dipeptidyl peptidase-4 on cardiac fibrosis in pressure overload-induced heart failure
by: Masanori Hirose, et al.
Published: (2017-12-01)

Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart
by: Ajit Magadum, et al.
Published: (2021-05-01)

Effect of Peritoneal Dialysis on Serum Fibrosis Biomarkers in Patients with Refractory Congestive Heart Failure
by: Margarita Kunin, et al.
Published: (2019-05-01)

Effect of adjuvant Shenqi injection therapy on cardiac function and myocardial fibrosis in patients with refractory heart failure
by: San-Wu Wu, et al.
Published: (2018-04-01)

The Role of MMP-13 in Cardiac Remodeling and Fibrosis
by: Schafer, Allison E.
Published: (2018)

Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT
by: Anthony E. Peters, et al.
Published: (2021-04-01)

Cardiac Fibroblasts and Cardiac Fibrosis: Precise Role of Exosomes
by: Prabhat Ranjan, et al.
Published: (2019-12-01)

The association between platelet-to-lymphocyte ratio with mortality among patients suffering from acute decompensated heart failure
by: Maryam Heidarpour, et al.
Published: (2021-09-01)

Ca2+ Cycling Impairment in Heart Failure Is Exacerbated by Fibrosis: Insights Gained From Mechanistic Simulations
by: Maria T. Mora, et al.
Published: (2018-08-01)

Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
by: Rajinikanth Gogiraju, et al.
Published: (2019-03-01)

A case presentation of patient from northern China with endomyocardial fibrosis
by: Yonggang Yuan, et al.
Published: (2019-12-01)

Endogenous CCN5 Participates in Angiotensin II/TGF-β1 Networking of Cardiac Fibrosis in High Angiotensin II-Induced Hypertensive Heart Failure
by: Anan Huang, et al.
Published: (2020-09-01)

Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial
by: Job A. J. Verdonschot, et al.
Published: (2021-08-01)

Level of galectin-3 and ST2 in ischemic chronic heart failure depending on the functional state of kidneys
by: V. D. Syvolap, et al.
Published: (2014-12-01)

Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction
by: Francesca Graziani, et al.
Published: (2021-04-01)

Neutrophil-to-lymphocyte ratio and in-hospital mortality in patients with acute heart failure
by: Murat Turfan, et al.
Published: (2014-03-01)

Pathophysiological roles of Fgf signaling in the heart
by: Nobuyuki eItoh, et al.
Published: (2013-09-01)

Neutrophil to lymphocyte ratio predicts poor functional capacity in patients with heart failure
by: Musa Çakıcı, et al.
Published: (2014-10-01)

Positron Emission Tomography Techniques to Measure Active Inflammation, Fibrosis and Angiogenesis: Potential for Non-invasive Imaging of Hypertensive Heart Failure
by: Viktoria Balogh, et al.
Published: (2021-08-01)

Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
by: Yixin Zou, et al.
Published: (2018-11-01)

Treatment effect of Shenqi injection in patients with refractory heart failure and its influence on myocardial fibrosis
by: Xiao-Hong Zhang
Published: (2017-05-01)

The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats
by: Hsiang-Chun Lee, et al.
Published: (2019-04-01)

Novel Biomarkers in Heart Failure: New Insight in Pathophysiology and Clinical Perspective
by: Luigi Marzio Biasucci, et al.
Published: (2021-06-01)

Lymphocytopenia is associated with poor NYHA functional class in chronic heart failure patients with reduced ejection fraction
by: Hasan Yucel, et al.
Published: (2015-07-01)

Evaluation of phosphodiesterase 9A as a novel biomarker in heart failure with preserved ejection fraction
by: Christian Besler, et al.
Published: (2021-06-01)

The case for inhibiting p38 mitogen-activated protein kinase in heart failure
by: Pelin eArabacilar, et al.
Published: (2015-05-01)

CARTing Away Cardiac Fibrosis∗
by: Jonathan A. Epstein, MD
Published: (2020-03-01)

EVALUATION OF ATRIAL CONTRACTILE FUNCTION DISORDERS AND FIBROSIS AS PREDICTORS OF CHRONIC HEART FAILURE
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Role of Circulating Fibrocytes in Cardiac Fibrosis
by: Rong-Jie Lin, et al.
Published: (2016-01-01)

Galectin-3 in heart recipients
by: A. A. Ulybysheva, et al.
Published: (2019-07-01)